JP2002524410A5 - - Google Patents

Download PDF

Info

Publication number
JP2002524410A5
JP2002524410A5 JP2000568476A JP2000568476A JP2002524410A5 JP 2002524410 A5 JP2002524410 A5 JP 2002524410A5 JP 2000568476 A JP2000568476 A JP 2000568476A JP 2000568476 A JP2000568476 A JP 2000568476A JP 2002524410 A5 JP2002524410 A5 JP 2002524410A5
Authority
JP
Japan
Prior art keywords
mixture
composition
methylcellulose
lipase inhibitor
starch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000568476A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002524410A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/020744 external-priority patent/WO2000013667A1/en
Publication of JP2002524410A publication Critical patent/JP2002524410A/ja
Publication of JP2002524410A5 publication Critical patent/JP2002524410A5/ja
Pending legal-status Critical Current

Links

JP2000568476A 1998-09-08 1999-09-08 リプスタチン誘導体−可溶性繊維錠剤 Pending JP2002524410A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9939998P 1998-09-08 1998-09-08
US60/099,399 1998-09-08
PCT/US1999/020744 WO2000013667A1 (en) 1998-09-08 1999-09-08 Lipstatin derivative-soluble fiber tablets

Publications (2)

Publication Number Publication Date
JP2002524410A JP2002524410A (ja) 2002-08-06
JP2002524410A5 true JP2002524410A5 (cg-RX-API-DMAC7.html) 2006-11-02

Family

ID=22274826

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000568476A Pending JP2002524410A (ja) 1998-09-08 1999-09-08 リプスタチン誘導体−可溶性繊維錠剤

Country Status (8)

Country Link
US (2) US6607749B1 (cg-RX-API-DMAC7.html)
EP (1) EP1112063A4 (cg-RX-API-DMAC7.html)
JP (1) JP2002524410A (cg-RX-API-DMAC7.html)
AU (1) AU745697B2 (cg-RX-API-DMAC7.html)
CA (1) CA2342625A1 (cg-RX-API-DMAC7.html)
NZ (1) NZ510311A (cg-RX-API-DMAC7.html)
WO (1) WO2000013667A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200101904B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU745697B2 (en) * 1998-09-08 2002-03-28 Smithkline Beecham Corporation Lipstatin derivative-soluble fiber tablets
US20090060995A1 (en) * 2005-01-13 2009-03-05 Kamalinder Kaur Singh Dispersible sustained release pharmaceutical compositions
KR100572785B1 (ko) 2000-07-28 2006-04-19 에프. 호프만-라 로슈 아게 신규한 약학 조성물
DE10160409A1 (de) * 2001-12-10 2003-06-18 Guenther Beisel Verwendung von ionischen und nichtionischen Celluloseethern zur Herstellung eines gelartigen Mittels zur Verhinderung der Resorption von Fetten aus dem Magen-Darm-Trakt
US20040091450A1 (en) * 2002-02-26 2004-05-13 The Procter & Gamble Company Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body
US20080075688A1 (en) * 2003-10-31 2008-03-27 The Procter & Gamble Company Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body
WO2006085497A1 (ja) * 2005-02-09 2006-08-17 Kissei Pharmaceutical Co., Ltd. 口腔内崩壊錠
US20070123490A1 (en) * 2005-11-30 2007-05-31 Yokoyama Wallace H Preventing or reducing oxidative stress or oxidative cell injury
US20080119540A1 (en) * 2006-11-21 2008-05-22 D.N. Halgren Method of using oral lipase inhibitors to reduce plasma ghrelin and to prevent weight regain
GB0618725D0 (en) * 2006-09-23 2006-11-01 Jagotec Ag Composition containing inhibitors of gastro-intestinal lipase
CA2686257C (en) * 2007-05-16 2013-07-02 Buckman Laboratories International, Inc. Methods to control organic contaminants in fibers
SI2002825T1 (sl) * 2007-06-14 2013-10-30 Krka Farmacevtski sestavki, ki obsegajo orlistat
US20100112122A1 (en) * 2008-04-30 2010-05-06 Yun-Jeong Hong Method of preferentially reducing absorbability of saturated fatty acids
KR20100075260A (ko) * 2008-12-24 2010-07-02 주식회사종근당 리파아제 저해제의 부작용 개선을 위한 신규한 약제학적 조성물
CN102362863B (zh) * 2011-11-21 2013-06-12 山东新时代药业有限公司 一种含奥利司他的制剂及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5438167B2 (cg-RX-API-DMAC7.html) * 1974-04-27 1979-11-19
JPS608117B2 (ja) 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
GB2023604B (en) 1978-05-25 1982-07-28 Microbial Chem Res Found Physiologically active derivatives of esterastin and production thereof
US5374430A (en) * 1986-09-18 1994-12-20 London School Of Pharmacy Pharmaceutical formulation
US5576306A (en) * 1991-03-01 1996-11-19 Dow Chemical Company Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers
SK279677B6 (sk) * 1991-08-14 1999-02-11 Procter And Gamble Pharmaceuticals Cyklické deriváty močoviny a farmaceutický prostri
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
CA2128044C (en) 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
ES2234139T3 (es) * 1997-08-11 2005-06-16 Alza Corporation Forma de dosificacion de un agente activo de liberacion prolongada adaptada para la retencion gastrica.
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
AR016827A1 (es) * 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
CA2340056C (en) 1998-08-14 2007-01-09 F. Hoffmann-La Roche Ag Pharmaceutical compositions containing lipase inhibitors
PT1105123E (pt) 1998-08-14 2004-08-31 Hoffmann La Roche Composicoes farmaceuticas contendo inibidores da lipase e quitosano
AU745697B2 (en) * 1998-09-08 2002-03-28 Smithkline Beecham Corporation Lipstatin derivative-soluble fiber tablets
FR2795326B1 (fr) * 1999-06-28 2001-08-31 Adir Composition pharmaceutique solide thermoformable a liberation controlee

Similar Documents

Publication Publication Date Title
JP2001513545A5 (cg-RX-API-DMAC7.html)
AU2001268719B2 (en) Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
EP0859603B1 (en) Sustained release matrix for high-dose insoluble drugs
CA2182004C (en) Film coated tablet of paracetamol and domperidone
JPH11503763A (ja) 安定な医薬組成物
US20070104785A1 (en) Tablets of linezolid form iii and processes for their preparation
KR100694550B1 (ko) 고용량의 이반드로네이트 제형물
CA2361843C (en) Swallowable tablets with high content of n-acetylcysteine
NZ509832A (en) New oral formulation for 5-HT4 agonists or antagonists
JPS5883618A (ja) ニトロフラントイン投与剤
JP4970452B2 (ja) メトホルミン徐放性錠剤およびその製造方法
AU2004275569B2 (en) Pharmaceutical formulation with improved stability
CA2532485A1 (en) Tablets containing ambroxol
JP2012512242A (ja) ウデナフィル含有徐放性製剤を製造するための制御放出組成物
RU2704613C2 (ru) Фармацевтические препараты с фиксированной комбинацией доз обезболивающего и антиспазматического агентов
RU2007125122A (ru) Фармацевтический состав карбоксамидных ингибиторов интегразы вич, содержащий композицию с контролируемой скоростью высвобождения
AU2007263261B2 (en) Galenical formulations of aliskiren and hydrochlorothiazide
ES2286716T3 (es) Composicion farmaceutica de liberacion controlada y proceso para preparar la misma.
ES2259011T3 (es) Composicion farmaceutica para la liberacion controlada de un antibiotico beta-lactama.
CA2373962A1 (en) Immediate release medicinal compositions for oral use
JP2776837B2 (ja) 消化性潰瘍治療剤
GB2429645A (en) Solid pharmaceutical composition comprising a COMT inhibitor, a starch and a wetting agent
JPS62246512A (ja) 反復作用製剤
WO2009016577A2 (en) A pharmaceutical composition comprising atorvastatin and niacin
SI9200080B (sl) Farmacevtski sestavki, ki vsebujejo stisnjene granulate zdravila